FOLH1 and cancer: The current paper reveals an overall higher frequency of PSMA expression (scores 1 and 2) (59%) in the current cohort of 704 tumors covering the entire spectrum of biological behavior from benign to malignant tumors of soft tissue and bone, including vascular tumors (Table 1).